Mechanisms of resistance to cisplatin
- PMID: 1686719
- DOI: 10.1007/978-1-4615-3872-1_11
Mechanisms of resistance to cisplatin
Abstract
A number of changes have been detected in cisplatin-resistant cells, some of which are likely to be directly involved in the mechanism of resistance. The four most cited mechanisms are reduced accumulation, increased glutathione, increased metallothionein, and enhanced DNA repair. Of these mechanisms, reduced accumulation is probably the most common. Detoxification by glutathione or metallothionein may occur in some circumstances, but the evidence is often ambivalent. Enhanced DNA repair has been observed in several cases, but, to date, few cell lines have been adequately investigated for such changes. These observations demonstrate that multiple mechanisms of resistance exist, and often several may occur in the same cell line. To understand the significance of specific mechanisms, many laboratories are attempting to obtain genetic probes. These probes will then be used to clarify the mechanisms of resistance in fresh clinical samples and hopefully will facilitate improvements in therapeutic response.
Similar articles
-
Mechanisms of acquired resistance to cisplatin.Cancer Treat Res. 1994;73:217-48. doi: 10.1007/978-1-4615-2632-2_11. Cancer Treat Res. 1994. PMID: 7710906 Review. No abstract available.
-
The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents.Biochem Pharmacol. 1993 Jan 7;45(1):253-6. doi: 10.1016/0006-2952(93)90399-h. Biochem Pharmacol. 1993. PMID: 8424817
-
Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.Int J Radiat Oncol Biol Phys. 1990 Jul;19(1):75-83. doi: 10.1016/0360-3016(90)90137-9. Int J Radiat Oncol Biol Phys. 1990. PMID: 2380098
-
[Mechanisms for resistance and cross-resistance patterns of cisplatin-resistant tumor lines].Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 2):509-14. Gan To Kagaku Ryoho. 1990. PMID: 2321979 Japanese.
-
The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin.Cancer Treat Rev. 1990 Dec;17(4):389-407. doi: 10.1016/0305-7372(90)90081-p. Cancer Treat Rev. 1990. PMID: 1982706 Review. No abstract available.
Cited by
-
Apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway.Cancer Med. 2018 Apr;7(4):1369-1383. doi: 10.1002/cam4.1380. Epub 2018 Mar 9. Cancer Med. 2018. PMID: 29522284 Free PMC article.
-
Gli1 contributes to cellular resistance to cisplatin through altered cellular accumulation of the drug.Oncol Rep. 2014 Aug;32(2):469-74. doi: 10.3892/or.2014.3257. Epub 2014 Jun 12. Oncol Rep. 2014. PMID: 24926795 Free PMC article.
-
Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.J Biol Inorg Chem. 2009 Mar;14(3):387-99. doi: 10.1007/s00775-008-0456-6. Epub 2008 Dec 4. J Biol Inorg Chem. 2009. PMID: 19052781
-
Klotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathway.PLoS One. 2013;8(2):e57391. doi: 10.1371/journal.pone.0057391. Epub 2013 Feb 21. PLoS One. 2013. PMID: 23437382 Free PMC article.
-
Cytoplasmic initiation of cisplatin cytotoxicity.Am J Physiol Renal Physiol. 2008 Jul;295(1):F44-52. doi: 10.1152/ajprenal.00593.2007. Epub 2008 Apr 9. Am J Physiol Renal Physiol. 2008. PMID: 18400869 Free PMC article.